buprenorphine and Retinal-Diseases

buprenorphine has been researched along with Retinal-Diseases* in 1 studies

Other Studies

1 other study(ies) available for buprenorphine and Retinal-Diseases

ArticleYear
Solar maculopathy and dissociative symptoms: a case report on a patient on buprenorphine opioid replacement therapy.
    The New Zealand medical journal, 2022, 04-14, Volume: 135, Issue:1553

    Solar maculopathy refers to thermal and photochemical macular damage caused by excessive exposure to light.1 Risk factors include behaviour (eg welding, sunbathing), refraction, pupillary size and clarity of ocular media.2 Drugs, both prescribed and recreational, can contribute to solar maculopathy through analgesic, photosensitization and psychiatric effects.2 We report a case of solar retinopathy associated with a brief dissociative episode. Written informed consent was obtained from the participant.

    Topics: Buprenorphine; Humans; Macular Degeneration; New Zealand; Opiate Substitution Treatment; Retinal Diseases

2022